Skip to main content

Genentech: No thanks, Roche

Roche won't be acquiring Genentech in the near future. Roche's bid to purchase the remaining public shares of the biotech company undermines the value of the company, Genentech's board of directors linkurl:announced today;https://www.gene.com/gene/news/press-releases/display.do?method=detail&id=11427 (August 13). Last month, Roche linkurl:put in a bid;https://www.the-scientist.com/blog/display/54841/ to buy up the remaining 44% of Genentech's shares it does not already own for $89 a share. A spe

Written byAndrea Gawrylewski
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Roche won't be acquiring Genentech in the near future. Roche's bid to purchase the remaining public shares of the biotech company undermines the value of the company, Genentech's board of directors linkurl:announced today;https://www.gene.com/gene/news/press-releases/display.do?method=detail&id=11427 (August 13). Last month, Roche linkurl:put in a bid;https://www.the-scientist.com/blog/display/54841/ to buy up the remaining 44% of Genentech's shares it does not already own for $89 a share. A special committee at Genentech said that it is rejecting this proposal, but will consider one that recognizes the company's true value. "Roche continues to believe its proposal is fair and generous, and has no further comment at this time," a spokesman for the pharmaceutical company told Dow Jones Newswires today. Roche's offer does not reflect Genentech's market performance: the biotech's stock was trading well over $98 this morning, the Wall Street Journal Health Blog linkurl:reported.;https://blogs.wsj.com/health/2008/08/13/genentech-to-roche-were-worth-more-than-that/
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Engineering Bispecific Antibodies Against Emerging Viruses

Engineering Bispecific Antibodies Against Emerging Viruses

innovative-research-horizontal-lock-inverted-rgb-900px-w-72ppi
Advancing Research With Humanized Mouse Models

Advancing Research with Next-Generation Humanized Mouse Models

bioxcell
3d illustration showing amyloid plaques in Alzheimer's disease

Best Practices for Blood-Based Amyloid Pathology Testing

fujirebio logo

Products

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation

A photograph of plastic fragments floating in water, symbolizing contamination from sample storage tubes.

LVL SAFE® 2D-Coded Tubes: The Perfect Tube for Your Sample

AutoGen